Evidence map›Paper›PMID 37052732›Full record

ArticleThe AAPS journal2023

In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.

David Tess, George C Chang, Christopher Keefer, Anthony Carlo, Rhys Jones, Li Di

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David TessModeling and Simulation, Pfizer Worldwide Research and Development, Cambridge, MA, USA.
George C ChangModeling and Simulation, Pfizer Worldwide Research and Development, Groton, CT, USA.
Christopher KeeferModeling and Simulation, Pfizer Worldwide Research and Development, Groton, CT, USA.
Anthony CarloDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, CT, USA.
Rhys JonesPharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, La Jolla, CA, USA.
Li DiPharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA. Li.Di@Pfizer.Com.ORCID http://orcid.org/0000-0001-6117-9022
Pfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro-in vivo extrapolation ((IVIVE) and empirical scaling factors (SF) of human intrinsic clearance (CL

Indexed as

LiverMicrosomes, LiverAnimalsHepatocytesHumansMetabolic Clearance RateModels, BiologicalProspective StudiesRatsclearance predictionfraction unbound in plasmahepatocytesIVIVEliver metabolismmicrosomesscaling factor

Identifiers

PMID37052732
OpenAlexW4365443608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.